Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia, Kidney Disease, Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02238067
What this trial is testing

Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis

Who this might be right for
Chronic Kidney Diseases
Hoffmann-La Roche 196
Not applicableStudy completedNCT00358306
What this trial is testing

The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)

Who this might be right for
Acute Renal FailureChronic Kidney FailureEndothelial Dysfunction+1 more
University of Alabama at Birmingham 36
Large-scale testing (Phase 3)Looking for participantsNCT07494409
What this trial is testing

AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia

Who this might be right for
Anemia Due to Chronic Kidney Disease
Kind Pharmaceuticals LLC 300
Testing effectiveness (Phase 2)Study completedNCT04885647
What this trial is testing

YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease

Who this might be right for
Renal Anemia of Chronic Kidney Disease
Xiamen Amoytop Biotech Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT01478971
What this trial is testing

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

Who this might be right for
Chronic Kidney DiseaseAnemia
Takeda 184
Large-scale testing (Phase 3)Study completedNCT01652872
What this trial is testing

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease

Who this might be right for
Anemia in Chronic Kidney Disease Patients Not on Dialysis
Amgen 756
Post-approval studies (Phase 4)UnknownNCT03388385
What this trial is testing

Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD

Who this might be right for
Renal AnemiaIron ToxicityOxidative Stress+1 more
Carol Davila University of Medicine and Pharmacy 40
Early research (Phase 1)Study completedNCT00270478
What this trial is testing

Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia

Who this might be right for
Sickle Cell DiseaseChronic Kidney DiseasePulmonary Hypertension
National Heart, Lung, and Blood Institute (NHLBI) 7
Not applicableStudy completedNCT06994065
What this trial is testing

Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients

Who this might be right for
Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Sindh Institute of Urology and Transplantation 128
Not applicableStudy completedNCT02191150
What this trial is testing

Study of Haemodialysis Patients Switching From Aranesp to Biosimilar

Who this might be right for
Anaemia
Amgen 272
Not applicableEnded earlyNCT03214627
What this trial is testing

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial

Who this might be right for
AnemiaEnd Stage Renal Disease
Vifor Fresenius Medical Care Renal Pharma 88
Large-scale testing (Phase 3)Study completedNCT02876835
What this trial is testing

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Who this might be right for
Anaemia
GlaxoSmithKline 3,872
Large-scale testing (Phase 3)Looking for participantsNCT07487727
What this trial is testing

AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

Who this might be right for
Anemia Due to Chronic Kidney Disease
Kind Pharmaceuticals LLC 240
Large-scale testing (Phase 3)Not Yet RecruitingNCT07565701
What this trial is testing

Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis

Who this might be right for
Anemia Associated With Chronic Kidney Disease
Geoff Block 100
Large-scale testing (Phase 3)Study completedNCT00440557
What this trial is testing

An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 375
Not applicableStudy completedNCT03218865
What this trial is testing

Influence of the Vitamine E Coated Dialyzer on Inflammation and Anemia

Who this might be right for
End Stage Renal DiseaseInflammation
Hemotech 120
Not applicableNot Yet RecruitingNCT07268807
What this trial is testing

Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease

Who this might be right for
Heart FailureCKDAnemia
Zhongda Hospital 200
Post-approval studies (Phase 4)UnknownNCT00247507
What this trial is testing

The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients

Who this might be right for
AnemiaAtherosclerosisEnd-Stage Renal Disease+2 more
Far Eastern Memorial Hospital
Large-scale testing (Phase 3)Study completedNCT00236977
What this trial is testing

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

Who this might be right for
Anemia
American Regent, Inc. 182
Large-scale testing (Phase 3)Study completedNCT02780141
What this trial is testing

Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia

Who this might be right for
ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc 75
Next Page